Los Angeles Times Examines New Contraceptive FemCap, Which Could Prevent HIV, STDs When Used With Microbicide
The Los Angeles Times today examines the new female contraceptive device FemCap, which could protect against HIV and other sexually transmitted diseases if used in conjunction with a microbicide (Allen, Los Angeles Times, 4/28). FemCap is made from silicone rubber, which its developers said is less irritating than similar latex contraceptives, and can be worn for up to 48 hours, double the time recommended for similar birth control devices. A single FemCap can be reused for two years, costs approximately $2 per month and comes in three sizes. The device, which works to prevent pregnancy by completely covering the cervix to stop sperm from reaching the uterus, is also equipped with a delivery system for microbicides and spermicides (Kaiser Daily HIV/AIDS Report, 4/24). The device received FDA approval last month and is currently on the market (Los Angeles Times, 4/28).
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
